Business Context and Reporting Period
This Form 6-K filing by Apollomics Inc. covers the month of October 2025, with the report dated October 15, 2025. The filing primarily addresses a change in the Company's independent registered public accounting firm and the resolution of a Nasdaq listing compliance matter.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and regulatory status rather than financial performance data.
Material Changes
- Change of Auditor: On October 13, 2025, the Audit Committee dismissed Grant Thornton LLP and appointed Marcum Asia CPAs LLP as the new independent registered public accounting firm, effective immediately.
- Audit History: Grant Thornton's reports for the fiscal years ended December 31, 2023, and 2024, contained no adverse opinions, disclaimers, or qualifications. No disagreements on accounting principles or audit scope occurred during these periods.
- Internal Controls: A material weakness in internal control over financial reporting identified as of December 31, 2023, was remediated during 2024.
- Nasdaq Listing Status: On October 14, 2025, Nasdaq determined the Company is in compliance with continued listing requirements. Consequently, a scheduled appeal hearing was cancelled, and the Company's securities will remain listed and trade on The Nasdaq Stock Market.
Guidance, Outlook, and Risks
The filing includes a cautionary statement regarding forward-looking statements related to the development and commercialization of vebreltinib, future proceedings regarding Cayman Litigation, and the outcome of the Nasdaq delisting notification. Management notes that these statements are subject to unknown risks and uncertainties detailed in the Annual Report on Form 20-F for the year ended December 31, 2024. The Company undertakes no obligation to update these statements except as required by law.
Investor Verification Checklist
- Verify the effective date of the transition from Grant Thornton LLP to Marcum Asia CPAs LLP.
- Confirm the status of the remediation of the material weakness in internal controls reported in the 2023 fiscal year.
- Review the press release filed as Exhibit 99.1 for details on the Nasdaq compliance determination.
- Examine the concurrence letter from Grant Thornton LLP (Exhibit 16.1) to ensure no undisclosed disagreements exist.
- Consult the most recent Form 20-F for updated financial metrics and risk factors not included in this 6-K.